Abacavir
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2519 publications
Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial.
Journal: The Pediatric infectious disease journal
Published: February 24, 2026
Kidney Disease in HIV Infected Children on HAART in Nigeria.
Journal: African health sciences
Published: February 05, 2026
Agricultural dissolved black carbon modulates photodegradation of antiviral drug: Insights from optical and molecular signatures.
Journal: Journal of hazardous materials
Published: December 20, 2025
Epigenetic Landscape of Female Infertility: An Integrated Bioinformatics Perspective on DNA Methylation, MicroRNAs, and Gene Regulatory Networks Across PCOS, Endometriosis, and Diminished Ovarian Reserve.
Journal: International journal of molecular sciences
Published: December 17, 2025
High-throughput screening for class I peptide MHC binding via yeast surface display.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 20, 2025
Safety and Effectiveness Analysis of Dolutegravir and Dolutegravir/Abacavir/Lamivudine in Japanese People Living with HIV: 10 years of Post-Marketing Surveillance.
Journal: Advances in therapy
Published: November 06, 2025
Repurposing of FDA-Approved Antiviral Drugs Against Monkeypox Virus: Comparative In Vitro Screening and Structure Based In Silico Studies.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 22, 2025
Preferential Recognition of Drug-Induced Altered Self-Presentation on Tumor Cells, but Not Host Cells, by CD8+ T Cells for Eliciting Anti-Tumor Immunity.
Journal: Biological & pharmaceutical bulletin
Published: October 22, 2025
Persistence on dolutegravir-containing two- and three-drug-regimens in clinical practice.
Journal: International journal of STD & AIDS
Published: October 03, 2025
Eco-friendly nanoscale recognition: a MIP-based electrochemical sensor for selective determination of abacavir in pharmaceutical and serum samples.
Journal: Analytical and bioanalytical chemistry
Published: September 29, 2025
Type I and II Interferons Drive Abacavir Hypersensitivity via Treg Suppression and T-Cell Enhancement in Immunocompetent HLA-Transgenic Mice.
Journal: Allergy
Published: September 23, 2025
Last Updated: 04/28/2026